Concurrent Hyperfractionated Radiation Therapy and Low Dose, Daily Chemotherapy as an Effective and Low Toxicity Approach in Locally Advanced (Stage III) Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Concurrent Hyperfractionated Radiation Therapy and Low Dose, Daily Chemotherapy as an Effective and Low Toxicity Approach in Locally Advanced (Stage III) Non–Small-Cell Lung Cancer

Published:2014-05 Issue:3 Volume:15 Page:e31-e32
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Jeremić Branislav

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference8 articles.

1. Toxicity of concurrent radiochemotherapy for locally advanced non–small-cell lung cancer: a systematic review of the literature;Koning;Clin Lung Cancer,2013

2. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation;Bartelink;Radiother Oncol,1986

3. Effects of concomitant cisplatin and radiotherapy on inoperable non–small-cell lung cancer;Schaake-Koning;N Engl J Med,1992

4. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non–small-cell lung cancer;Jeremic;J Clin Oncol,1995

5. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non–small-cell lung cancer: a randomized study;Jeremic;J Clin Oncol,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies;Oncotarget;2017-04-10

2. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer;Clinical Lung Cancer;2016-11

3. Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment;European Journal of Pharmaceutics and Biopharmaceutics;2014-11